Neuroprotective effect of Ro5-4864 following brain injury

Experimental Neurology

Volumn 214, Issue 2, 2008, Pages 201-208

  Soustiel, Jean F ^a   Zaaroor, Menashe ^a   Vlodavsky, Eugene ^b   Veenman, Leo ^a   Weizman, Abraham ^c   Gavish, Moshe ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

18 kDa translocator protein (TSPO); Apoptosis; Brain injury; Mitochondria

Indexed keywords

4' CHLORODIAZEPAM; CASPASE 3; CASPASE 8; CASPASE 9; DIMETHYL SULFOXIDE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PROTEIN BAX; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN INJURY; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NERVE CELL NETWORK; NEUROFILAMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TISSUE SECTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZODIAZEPINONES; BRAIN INJURIES; CARRIER PROTEINS; CASPASES; CONVULSANTS; DISEASE MODELS, ANIMAL; ISOQUINOLINES; LIGANDS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A;

EID: 56749175080     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.08.008     Document Type: Article

References (43)

1. Azarashvili T., Grachev D., Krestinina O., Evtodienko Y., Yurkov I., Papadopoulos V., and Reiser G. The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria. Cell Calcium 42 (2007) 27-39
2. Banker D.E., Cooper J.J., Fennell D.A., Willman C.L., Appelbaum F.R., and Cotter F.E. PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. Leuk. Res. 26 (2002) 91-106
3. Bono F., Lamarche I., Prabonnaud V., Le Fur G., and Herbert J.M. Peripheral benzodiazepine receptor agonists exhibit potent antiapoptotic activities. Biochem. Biophys. Res. Commun. 265 (1999) 457-461
4. Braestrup C., and Squires R.F. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc. Natl. Acad. Sci. U. S. A 74 (1977) 3805-3809
5. Bras M., Queenan B., and Susin S.A. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc.) 70 (2005) 231-239
6. Carmel I., Fares F.A., Leschiner S., Scherubl H., Weisinger G., and Gavish M. Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line. Biochem. Pharmacol. 58 (1999) 273-278
7. Castedo M., Perfettini J.L., and Kroemer G. Mitochondrial apoptosis and the peripheral benzodiazepine receptor: a novel target for viral and pharmacological manipulation. J. Exp. Med. 196 (2002) 1121-1125
8. Chelli B., Lena A., Vanacore R., Da Pozzo E., Costa B., Rossi L., Salvetti A., Scatena F., Ceruti S., Abbracchio M.P., Gremigni V., and Martini C. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem. Pharmacol. 68 (2004) 125-134
9. Decaudin D. Peripheral benzodiazepine receptor and its clinical targeting. Anticancer Drugs 15 (2004) 737-745
10. Decaudin D., Castedo M., Nemati F., Beurdeley-Thomas A., De Pinieux G., Caron A., Pouillart P., Wijdenes J., Rouillard D., Kroemer G., and Poupon M.F. Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res. 62 (2002) 1388-1393
11. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
12. Fennell D.A., Corbo M., Pallaska A., and Cotter F.E. Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species. Br. J. Cancer 84 (2001) 1397-1404
13. Gonzalez-Polo R.A., Carvalho G., Braun T., Decaudin D., Fabre C., Larochette N., Perfettini J.L., Djavaheri-Mergny M., Youlyouz-Marfak I., Codogno P., Raphael M., Feuillard J., and Kroemer G. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene (2005)
14. Green D.R., and Kroemer G. Pharmacological manipulation of cell death: clinical applications in sight?. J. Clin. Invest. 115 (2005) 2610-2617
15. Hirsch T., Decaudin D., Susin S.A., Marchetti P., Larochette N., Resche-Rigon M., and Kroemer G. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell Res. 241 (1998) 426-434
16. Jiang X., and Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275 (2000) 31199-31203
17. Jorda E.G., Jimenez A., Verdaguer E., Canudas A.M., Folch J., Sureda F.X., Camins A., and Pallas M. Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis. Apoptosis 10 (2005) 91-104
18. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., and Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. U. S. A 95 (1998) 4997-5002
19. Kroemer G., Dallaporta B., and Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60 (1998) 619-642
20. Kroemer G., Galluzzi L., and Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87 (2007) 99-163
21. Kugler W., Veenman L., Shandalov Y., Leschiner S., Spanier I., Lakomek M., and Gavish M. Ligands of the 18 kDa translocator protein atteuate apoptosis in human glioblastoma cells exposed to erucylphosphomocholine. Cell. Oncol. 30 (2008) 435-450
22. Le Fur G., Vaucher N., Perrier M.L., Flamier A., Benavides J., Renault C., Dubroeucq M.C., Gueremy C., and Uzan A. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci. 33 (1983) 449-457
23. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86 (1996) 147-157
24. Loeffler M., Daugas E., Susin S.A., Zamzami N., Metivier D., Nieminen A.L., Brothers G., Penninger J.M., and Kroemer G. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J. 15 (2001) 758-767
25. Maaser K., Hopfner M., Jansen A., Weisinger G., Gavish M., Kozikowski A.P., Weizman A., Carayon P., Riecken E.O., Zeitz M., and Scherubl H. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br. J. Cancer 85 (2001) 1771-1780
26. Maaser K., Sutter A.P., and Scherubl H. Mechanisms of mitochondrial apoptosis induced by peripheral benzodiazepine receptor ligands in human colorectal cancer cells. Biochem. Biophys. Res. Commun. 332 (2005) 646-652
27. McEnery M.W., Snowman A.M., Trifiletti R.R., and Snyder S.H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U. S. A 89 (1992) 3170-3174
28. Merenda A., and Bullock R. Clinical treatments for mitochondrial dysfunctions after brain injury. Curr. Opin. Crit. Care 12 (2006) 90-96
29. Mills C.D., Bitler J.L., and Woolf C.J. Role of the peripheral benzodiazepine receptor in sensory neuron regeneration. Mol. Cell Neurosci. 30 (2005) 228-237
30. Nakamoto Y., Watabe S., Shiotani T., and Yoshii M. Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice. Brain Res. 717 (1996) 91-98
31. Okonkwo D.O., and Povlishock J.T. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J. Cereb. Blood Flow Metab. 19 (1999) 443-451
32. Palzur E., Vlodavsky E., Mulla H., Arieli R., Feinsod M., and Soustiel J.F. Hyperbaric oxygen therapy for reduction of secondary brain damage in head injury: an animal model of brain contusion. J. Neurotrauma 21 (2004) 41-48
33. Reers M., Smith T.W., and Chen L.B. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30 (1991) 4480-4486
34. Shiotani T., Nakamoto Y., Watabe S., Yoshii M., and Nabeshima T. Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors. Brain Res. 859 (2000) 255-261
35. Shreiber D.I., Bain A.C., Ross D.T., Smith D.H., Gennarelli T.A., McIntosh T.K., and Meaney D.F. Experimental investigation of cerebral contusion: histopathological and immunohistochemical evaluation of dynamic cortical deformation. J. Neuropathol. Exp. Neurol. 58 (1999) 153-164
36. Soustiel J.F., Palzur E., Nevo O., Thaler I., and Vlodavsky E. Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J. Neurotrauma 22 (2005) 345-352
37. Sullivan P.G., Thompson M.B., and Scheff S.W. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp. Neurol. 160 (1999) 226-234
38. Susin S.A., Daugas E., Ravagnan L., Samejima K., Zamzami N., Loeffler M., Costantini P., Ferri K.F., Irinopoulou T., Prevost M.C., Brothers G., Mak T.W., Penninger J., Earnshaw W.C., and Kroemer G. Two distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192 (2000) 571-580
39. Veenman L., Leschiner S., Spanier I., Weisinger G., Weizman A., and Gavish M. PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain. J. Neurochem. 80 (2002) 917-927
40. Veiga S., Azcoitia I., and Garcia-Segura L.M. Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J. Neurosci. Res. 80 (2005) 129-137
41. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., and Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 (2000) 43-53
42. Waterhouse N.J., Goldstein J.C., von Ahsen O., Schuler M., Newmeyer D.D., and Green D.R. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J. Cell Biol. 153 (2001) 319-328
43. Zou H., Li Y., Liu X., and Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274 (1999) 11549-11556